Institutional variation in hemotherapy for solid organ transplantation

Transfusion

Volumn 36, Issue 3, 1996, Pages 263-267

  Danielson, C F M ^a   Filo, R S ^a   O'Donnell, J A ^a   Mccarthy, L J ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; BLOOD COMPONENT THERAPY; CRYOPRECIPITATE; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; PLASMA TRANSFUSION; THROMBOCYTE TRANSFUSION;

EID: 0029911792     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36396182147.x     Document Type: Article

References (44)

1. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantation of the human kidney between identical twins. JAMA 1956;160:277-82.
2. Facts about transplantation in the United States (fact sheet). Richmond, VA: United Network for Organ Sharing (UNOS), 1993.
3. Danielson CF. Transfusion support and complicating coagulopathies in solid organ transplantation. In: Hackel E, AuBuchon J, eds. Advances in transplantation. Bethesda: American Association of Blood Banks, 1993:43-73.
4. Ho M, Suwansirikul S, Dowling JN, et al. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 1975;293:1109-12.
5. Smiley ML, Wlodaver CG, Grossman RA, et al. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985;40:157-61.
6. Chou S. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J Infect Dis 1989;160:11-5.
7. Dummer JS. Cytomegalovirus infection after liver transplantation: clinical manifestations and strategies for prevention. Rev Infect Dis 1990;12(Suppl):S767-75.
8. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(Suppl):S754-66
9. Smyth RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991;164:1045-50.
10. Leitman SF, Holland PV. Irradiation of blood products: indications and guidelines. Transfusion 1985;25:293-300.
11. Brubaker DB. Transfusion-associated graft-versus-host disease. Hum Pathol 1986;17:1085-8.
12. Anderson KC, Goodnough LT, Sayers M, et al. Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991;77:2096-102.
13. Allen NH, Dyer P, Geoghegan T, et al. Plasma exchange in acute renal allograft rejection. A controlled trial. Transplantation 1983;35:425-8.
14. Blake P, Sutton D, Cardella CJ. Plasma exchange in acute renal transplant rejection. Prog Clin Biol Res 1990;337:249-52.
15. Frasca GM, Martella D, Vangelista A, Bonomini V. Ten years experience with plasma exchange in renal transplantation. Int J Artif Organs 1991,14:51-5.
16. Agishi T, Takahashi K, Ota K, Yagisawa T. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or -B antibody in ABO-incompatible kidney transplantation. Transplant Proc 1992;24:557-8.
17. Partanen J, Nieminen MS, Krogerus L, et al. Heart transplant rejection treated with plasmapheresis. J Heart Lung Transplant 1992;11:301-5.
18. Malafa M, Mancini MC, Myles JL, et al Successful treatment of acute humoral rejection in a heart transplant patient. J Heart Lung Transplant 1992;11:486-91.
19. Takahashi K, Yagisawa T, Sonda K, et al ABO-incompatible kidney transplantation in a single-center trial Transplant Proc 1993;25:271-3.
20. Aswad S, Mendez R, Mendez RG, et al. Crossing the ABO blood barrier in renal transplantation. Transplant Proc 1993;25:267-70.
21. Bontempo FA, Lewis JH, Van Thiel DH, et al. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 1985;39:532-6.
22. Lewis JH, Bontempo FA, Cornell F, et al. Blood use in liver transplantation. Transfusion 1987;27:222-5.
23. Farrar RP, Hanto DW, Flye MW, Chaplin H. Blood component use in orthotopic liver transplantation. Transfusion 1988;28:474-8.
24. Motschman TL, Taswell HF, Brecher ME, et al. Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. Mayo Clin Proc 1989;64 346-55.
25. Gerlach H, Rossaint R, Bechstein WO, et al. Goal-directed transfusion management leads to distinct reduction of fluid requirement in liver transplantation. Semin Thromb Hemost 1993;19:282-5
26. Deakin M, Gunson BK, Dunn JA, et al. Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Engl 1993;75:339-44.
27. Preiksaitis JK. Indications for the use of cytomegalovirus-seronegative blood products. Transfus Med Rev 1991;5:1-17.
28. Murphy MF, Grint PC, Hardiman AE, et al. Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia (letter). Br J Haematol 1988;70:253-4.
29. De Graan-Hentzen YCE, Gratama JW, Mudde GC, et al. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989;29:757-60.
30. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;1:1228-31.
31. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
32. Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion 1991;31:76-86.
33. Andersen CB, Ladefoged SD, Taaning E. Transfusion-associated graft-versus-graft and potential graft-versus-host disease in a renal allotransplanted patient. Hum Pathol 1992;23:831-4.
34. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:I127-52.
35. Sola MA, España A, Redondo P, et al. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient. Br J Dermatol 1995;132:626-30.
36. Klein HG, ed. Standards for blood banks and transfusion services, 16th ed. Bethesda: American Association of Blood Banks, 1994.
37. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-9.
38. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet 1983;2:986-9.
39. Brynger H, Persson H, Flatmark A, et al. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience. Transplant Proc 1988;20:261-3.
40. Ahmed Z, Terasaki PI Effect of transfusions. In: Terasaki P, Ceka JM, eds. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1991:305-12.
41. Evans RW. Need, demand, and supply in organ transplantation. Transplant Proc 1992;24:2152-4.
42. Caplan AL. Current ethical issues in organ procurement and transplantation. JAMA 1994;272:1708-9.
43. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993;56:554-61.
44. Hosenpud JD, Breen TJ, Edwards EB, et al. The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry. JAMA 1994;271:1844-9.